Biocon Ltd, an innovation-led global biopharmaceuticals company, announced that it has received the Drugs Controller General of India’s (DCGI) approval to market Itolizumab (ALZUMAb) Injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome (CRS) in moderate to severe ARDS (acute respiratory distress syndrome) patients due to COVID-19. Itolizumab is…
Biocon Ltd, an innovation-led global biopharmaceuticals company, announced that its subsidiary Biocon Biologics has received the Drugs Controller General of India’s (DCGI) approval for an extracorporeal blood purification (EBP) device CytoSorb to reduce pro-inflammatory cytokines levels in confirmed COVID-19 patients admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure. The company…
Biocon Ltd. and Biocon Biologics have activated business continuity plans across their functions to meet the needs of patients, partners, customers and other stakeholders who depend on its products. As a global company, it has presence across India, UAE, Malaysia, Singapore, Europe, U.S. and are adjusting all operations to fully comply with regulations issued by…
After violence broke out inside the Jawaharlal Nehru University yesterday with masked goons barging into the campus, several businessmen and corporate leaders took to Twitter addressing their concerns on safety inside educational establishments and universities. Among these business leaders were industrialists Anand Mahindra,Harsh Mariwala, Apurva Purohit and Kiran Mazumdar Shaw who called for strict action…
Biocon Ltd, an innovation-led global biopharmaceuticals company, today announced that the Board of its subsidiary Biocon Biologics India Ltd has approved a primary equity investment by True North. As per the terms of the proposed agreement, True North will invest ₹ 536.25 Crore that will eventually translate to a 2.44% minority stake in the biosimilars…
Biocon Ltd, an innovation-led global biopharmaceuticals company, announced that Siddharth Mittal has taken over as Chief Executive Officer & Joint Managing Director of the Company starting December 1, 2019. Mr. Mittal has been serving as Biocon’s Chief Financial Officer since August 2014. Welcoming Mr. Mittal, CMD, Biocon, Kiran Mazumdar-Shaw said, “I am very pleased to…